State-of-the-art technologies provide new insights linking skin and blood vessel abnormalities in SSc-related disorders.


Journal

Microvascular research
ISSN: 1095-9319
Titre abrégé: Microvasc Res
Pays: United States
ID NLM: 0165035

Informations de publication

Date de publication:
07 2020
Historique:
received: 17 01 2020
revised: 07 04 2020
accepted: 10 04 2020
pubmed: 23 4 2020
medline: 24 9 2020
entrez: 23 4 2020
Statut: ppublish

Résumé

A key unanswered question in systemic sclerosis (SSc) is how microvascular abnormality and fibrosis inter-relate. Our aim was to use state-of-the-art non-invasive imaging methods to gain new insights into pathophysiology, comparing patients with different subtypes of SSc, including early dcSSc, not only to healthy controls but also to patients with causes of Raynaud's phenomenon not progressing to fibrosis. Laser Doppler imaging, nailfold capillaroscopy, spectroscopy, and ultrasound measured (respectively) perfusion, microvascular structure, oxygenation/oxidative stress, and skin thickening in the hands of 265 subjects: 31 patients with primary Raynaud's phenomenon (PRP), 35 with undifferentiated connective tissue disease (UCTD), 93 with limited cutaneous SSc (lcSSc), 46 with diffuse cutaneous SSc (dcSSc, including 27 'early') and 60 healthy controls. Mean perfusion was reduced in SSc groups compared to controls (lcSSc 172 perfusion units [standard deviation 157], late-dcSSc 90 [145], early-dcSSc 68 [137] vs. controls 211 [146]; p = 0.0002) as was finger-oxygenation (lcSSc 12.1 [13.6] arbitrary units [AU], late-dcSSc 12.2 [8.4], early-dcSSc 11.1 [11.3] vs controls 14.9 [10.5]; p = 0.0049). Oxidative stress was increased at the hand-dorsum in SSc groups (p = 0.0007). Perfusion positively correlated with oxygenation (r = 0.23, p < 0.001), and capillary density negatively with skin thickness (r = -0.26, p < 0.001). Our findings lend support to the hypothesis that in SSc, particularly early dcSSc, (but not in PRP or UCTD), reduced perfusion (together with structural microvascular abnormality) associates with reduced oxygenation, with oxidative stress and with skin thickening/fibrosis, most likely driving a vicious cycle which ultimately results in irreversible tissue injury. Findings in skin may mirror alterations in internal organs.

Identifiants

pubmed: 32320708
pii: S0026-2862(20)30066-2
doi: 10.1016/j.mvr.2020.104006
pmc: PMC7522709
pii:
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104006

Subventions

Organisme : Department of Health
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : 19465
Pays : United Kingdom

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflicts of interests.

Références

Ann Rheum Dis. 2014 Jan;73(1):247-51
pubmed: 23644551
Ann Rheum Dis. 2019 May;78(5):648-656
pubmed: 30852552
Clin Hemorheol Microcirc. 2015;60(3):263-71
pubmed: 23370157
Scand J Rheumatol. 2015;44(1):48-55
pubmed: 25379977
Physiol Meas. 2018 Apr 03;39(3):03NT02
pubmed: 29469817
J Rheumatol. 2001 Jul;28(7):1573-6
pubmed: 11469464
Arthritis Rheum. 2013 Nov;65(11):2737-47
pubmed: 24122180
Autoimmun Rev. 2019 Feb;18(2):177-183
pubmed: 30572139
Diabetes Care. 2006 Dec;29(12):2654-9
pubmed: 17130200
Semin Arthritis Rheum. 1975 May;4(4):351-68
pubmed: 1135634
Lasers Surg Med. 2004;35(3):191-200
pubmed: 15389741
Microvasc Res. 2018 Jul;118:173-177
pubmed: 29605552
Rheumatology (Oxford). 2006 Jul;45(7):815-8
pubmed: 16449367
Diabetes Technol Ther. 2006 Oct;8(5):523-35
pubmed: 17037967
Ann Rheum Dis. 2011 Jan;70(1):104-9
pubmed: 20679474
Microvasc Res. 2018 Jan;115:28-33
pubmed: 28834709
J Rheumatol. 2010 Sep;37(9):1968-9
pubmed: 20810526
Arthritis Res Ther. 2009;11(2):220
pubmed: 19473554
Thorax. 2009 Jul;64(7):626-30
pubmed: 19359269
Clin Exp Rheumatol. 2001 Jan-Feb;19(1):4-8
pubmed: 11247323
Arthritis Rheum. 2009 Aug 15;61(8):1103-11
pubmed: 19644893
J Rheumatol. 1988 Feb;15(2):202-5
pubmed: 3361530
J Pathol. 1999 Oct;189(2):273-8
pubmed: 10547586
Arthritis Rheum. 2007 Dec;56(12):4203-15
pubmed: 18050252
Arthritis Rheum. 2003 Aug;48(8):2246-55
pubmed: 12905479
Microvasc Res. 2011 Nov;82(3):410-5
pubmed: 21816163
Open Rheumatol J. 2012;6:87-95
pubmed: 22802906
Med Image Comput Comput Assist Interv. 2014;17(Pt 1):658-65
pubmed: 25333175
Front Physiol. 2018 Aug 24;9:1177
pubmed: 30197602
Comput Methods Programs Biomed. 2018 Mar;155:101-108
pubmed: 29512489
J Rheumatol. 1995 Jul;22(7):1281-5
pubmed: 7562759
Semin Arthritis Rheum. 2019 Apr;48(5):867-873
pubmed: 30205980
Rheumatology (Oxford). 2009 Aug;48(8):876-82
pubmed: 19542215
Rheumatol Int. 2018 Dec;38(12):2279-2288
pubmed: 30206672
Free Radic Biol Med. 2015 Oct;87:282-9
pubmed: 26143738
Rheumatology (Oxford). 2007 Mar;46(3):412-6
pubmed: 16936331
Curr Opin Rheumatol. 2000 Nov;12(6):527-33
pubmed: 11092203
Curr Rheumatol Rep. 2015 Jan;17(1):473
pubmed: 25475596
Dis Markers. 2015;2015:837470
pubmed: 26880854
Arthritis Rheumatol. 2014 Jun;66(6):1616-24
pubmed: 24470430
Microvasc Res. 2016 May;105:119-24
pubmed: 26907637
Clin Exp Immunol. 2006 Nov;146(2):362-70
pubmed: 17034590
Semin Arthritis Rheum. 2019 Oct;49(2):273-278
pubmed: 30853116
Cardiol Res Pract. 2012;2012:521958
pubmed: 22111028
J Rheumatol. 2012 Aug;39(8):1654-8
pubmed: 22753661
Diabetes Care. 2007 Jan;30(1):107-12
pubmed: 17192342
J Scleroderma Relat Disord. 2018 Jun;3(2):159-169
pubmed: 29808171
Arthritis Res Ther. 2010;12(4):R157
pubmed: 20696074
Int J Rheumatol. 2011;2011:824972
pubmed: 22162692
Rheumatology (Oxford). 2007 Mar;46(3):533-8
pubmed: 17018538

Auteurs

Graham Dinsdale (G)

Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom of Great Britain and Northern Ireland; Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom of Great Britain and Northern Ireland.

Sarah Wilkinson (S)

Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom of Great Britain and Northern Ireland; Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom of Great Britain and Northern Ireland.

Jack Wilkinson (J)

Centre for Biostatistics, Manchester Academic Health Science Centre, Faculty of Biology, Medicine and Health The University of Manchester, United Kingdom of Great Britain and Northern Ireland.

Tonia L Moore (TL)

Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom of Great Britain and Northern Ireland; Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom of Great Britain and Northern Ireland.

Joanne B Manning (JB)

Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom of Great Britain and Northern Ireland; Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom of Great Britain and Northern Ireland.

Michael Berks (M)

Centre for Imaging Sciences, Division of Informatics, Imaging and Data Sciences, The University of Manchester, Manchester, United Kingdom of Great Britain and Northern Ireland.

Elizabeth Marjanovic (E)

Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom of Great Britain and Northern Ireland; Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom of Great Britain and Northern Ireland.

Mark Dickinson (M)

Photon Science Institute, The University of Manchester, Manchester, United Kingdom of Great Britain and Northern Ireland; The Dept of Physics and Astronomy, Unversity of Manchester, United Kingdom of Great Britain and Northern Ireland.

Ariane L Herrick (AL)

Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom of Great Britain and Northern Ireland; Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom of Great Britain and Northern Ireland. Electronic address: andrea.murray@manchester.ac.uk.

Andrea K Murray (AK)

Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom of Great Britain and Northern Ireland; Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom of Great Britain and Northern Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH